Venus Concept Inc (VERO) - Net Assets

Latest as of September 2025: $3.13 Million USD

Based on the latest financial reports, Venus Concept Inc (VERO) has net assets worth $3.13 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($61.62 Million) and total liabilities ($58.49 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read Venus Concept Inc balance sheet liabilities for a breakdown of total debt and financial obligations.

Key Net Assets Metrics

Metric Value
Current Net Assets $3.13 Million
% of Total Assets 5.09%
Annual Growth Rate N/A
5-Year Change -93.51%
10-Year Change N/A
Growth Volatility 1805.69

Venus Concept Inc - Net Assets Trend (2015–2024)

This chart illustrates how Venus Concept Inc's net assets have evolved over time, based on quarterly financial data. Also explore VERO total asset value for the complete picture of this company's asset base.

Annual Net Assets for Venus Concept Inc (2015–2024)

The table below shows the annual net assets of Venus Concept Inc from 2015 to 2024. For live valuation and market cap data, see Venus Concept Inc market cap and net worth.

Year Net Assets Change
2024-12-31 $2.84 Million +121.10%
2023-12-31 $-13.45 Million -253.91%
2022-12-31 $8.74 Million -78.99%
2021-12-31 $41.60 Million -4.95%
2020-12-31 $43.76 Million -42.93%
2019-12-31 $76.68 Million +4746.90%
2018-12-31 $1.58 Million -88.01%
2017-12-31 $13.19 Million +109.19%
2016-12-31 $-143.54 Million -17.46%
2015-12-31 $-122.20 Million --

Equity Component Analysis

This analysis shows how different components contribute to Venus Concept Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 18410000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $30.00K 1.27%
Other Components $311.24 Million 13137.95%
Total Equity $2.37 Million 100.00%

Venus Concept Inc Competitors by Market Cap

The table below lists competitors of Venus Concept Inc ranked by their market capitalization.

Company Market Cap
Zanaga Iron Ore Co Ltd
LSE:ZIOC
$500.31K
Onward Opportunities Ltd
LSE:ONWD
$500.54K
DCI Advisors Limited
LSE:DCI
$500.80K
HODL SPAC EUROPE AB
F:NW1
$501.13K
YUMY CANDY COMPANY INC.
F:FWR0
$497.21K
SDCL EDGE Acquisition Corporation
NYSE:SEDA
$492.28K
Redan S.A.
WAR:RDN
$491.38K
New Destiny Mining Corp
V:NED
$490.58K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Venus Concept Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from -14,019,000 to 2,369,000, a change of 16,388,000.
  • Net loss of 46,996,000 reduced equity.
  • New share issuances of 987,000 increased equity.
  • Other factors increased equity by 62,397,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-47.00 Million -1983.79%
Share Issuances $987.00K +41.66%
Other Changes $62.40 Million +2633.9%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Venus Concept Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.08x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2015-12-31 $-1192.81 $0.27 x
2016-12-31 $-1401.10 $0.27 x
2017-12-31 $113.04 $0.27 x
2018-12-31 $10.62 $0.27 x
2019-12-31 $130.64 $0.27 x
2020-12-31 $18.12 $0.27 x
2021-12-31 $11.28 $0.27 x
2022-12-31 $1.84 $0.27 x
2023-12-31 $-2.58 $0.27 x
2024-12-31 $3.34 $0.27 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Venus Concept Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -1983.79%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -72.49%
  • • Asset Turnover: 0.95x
  • • Equity Multiplier: 28.78x
  • Recent ROE (-1983.79%) is below the historical average (-477.31%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2015 0.00% -133.32% 0.65x 0.00x $-10.75 Million
2016 0.00% -140.04% 0.80x 0.00x $-7.49 Million
2017 -135.23% -83.78% 0.65x 2.50x $-19.16 Million
2018 -1815.80% -130.83% 0.71x 19.58x $-28.88 Million
2019 -57.02% -38.31% 0.58x 2.58x $-49.71 Million
2020 -187.24% -106.16% 0.49x 3.63x $-87.24 Million
2021 -54.08% -20.96% 0.67x 3.84x $-26.24 Million
2022 -539.97% -43.92% 0.79x 15.49x $-44.51 Million
2023 0.00% -48.79% 0.82x 0.00x $-35.85 Million
2024 -1983.79% -72.49% 0.95x 28.78x $-47.23 Million

Industry Comparison

This section compares Venus Concept Inc's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $2,432,799,891
  • Average return on equity (ROE) among peers: -74.29%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Venus Concept Inc (VERO) $3.13 Million 0.00% 18.66x $498.99K
Abbott Laboratories (ABT) $24.16 Billion 9.46% 0.81x $155.56 Billion
Adagio Medical Holdings, Inc Common Stock (ADGM) $-13.54K 0.00% 0.00x $21.60 Million
Aethlon Medical Inc (AEMD) $9.29 Million -84.45% 0.15x $2.79 Million
Acutus Medical Inc (AFIB) $105.73 Million -116.68% 0.61x $903.35K
Adapthealth Corp (AHCO) $15.14 Million -140.98% 14.05x $1.39 Billion
20/20 Biolabs, Inc. Common Stock (AIDX) $2.15 Million -112.84% 0.45x $16.04 Million
Allurion Technologies, Inc. (ALUR) $-70.49 Million 0.00% 0.00x $8.60 Million
Autonomix Medical, Inc. Common Stock (AMIX) $644.00K -309.01% 0.34x $4.22 Million
Artivion Inc (AORT) $89.39 Million 8.74% 0.25x $1.73 Billion
Apyx Medical Inc (APYX) $21.15 Million 2.82% 0.30x $125.55 Million

About Venus Concept Inc

NASDAQ:VERO USA Medical Devices
Market Cap
$498.99K
Market Cap Rank
#30552 Global
#5923 in USA
Share Price
$0.27
Change (1 day)
-11.42%
52-Week Range
$0.27 - $8.00
All Time High
$2232.00
About

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-app… Read more